Last reviewed · How we verify

NCT03684902

Burst Abdomen in Emergency Midline Laparotomy: Incidence and Risk

Completed NA Last updated 26 September 2018
What this trial tests

NA trial testing emergency midline exploratory laparotomy in Wound Dehiscence in 250 participants. Completed in 20 September 2018.

Timeline
5 August 2017
Primary endpoint
30 August 2018
20 September 2018

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment250
Start date5 August 2017
Primary completion30 August 2018
Estimated completion20 September 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 19 to 65, any sex, with Wound Dehiscence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was conducted in 250 patients who underwent midline Laparotomy at Kasr Al-Ainy emergency department, Cairo University from August 2017 until March 2018. Factors such as age ,sex, body mass index, substance abuse, previous laparotomy, malignancy, diabetes mellitus , ascites, albumin, renal functions, bilirubin, hemoglobin, intra-abdominal pathology, suture material, creation of stoma, post-operative chest infection, , post-operative paralytic ileus, leakage and wound infection were observed and analyzed with odds ratio and P value

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wound Dehiscence

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03684902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing